首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   4598篇
  免费   359篇
  国内免费   12篇
耳鼻咽喉   30篇
儿科学   139篇
妇产科学   50篇
基础医学   556篇
口腔科学   32篇
临床医学   616篇
内科学   925篇
皮肤病学   43篇
神经病学   389篇
特种医学   160篇
外科学   991篇
综合类   72篇
一般理论   5篇
预防医学   368篇
眼科学   94篇
药学   249篇
中国医学   4篇
肿瘤学   246篇
  2023年   43篇
  2022年   89篇
  2021年   218篇
  2020年   83篇
  2019年   157篇
  2018年   175篇
  2017年   136篇
  2016年   142篇
  2015年   182篇
  2014年   260篇
  2013年   288篇
  2012年   382篇
  2011年   386篇
  2010年   190篇
  2009年   175篇
  2008年   276篇
  2007年   253篇
  2006年   227篇
  2005年   227篇
  2004年   200篇
  2003年   194篇
  2002年   181篇
  2001年   17篇
  2000年   15篇
  1999年   20篇
  1998年   25篇
  1997年   14篇
  1996年   20篇
  1995年   13篇
  1994年   10篇
  1993年   9篇
  1992年   9篇
  1991年   10篇
  1989年   10篇
  1987年   13篇
  1986年   10篇
  1983年   12篇
  1982年   17篇
  1981年   13篇
  1980年   16篇
  1979年   20篇
  1978年   19篇
  1977年   13篇
  1976年   12篇
  1975年   12篇
  1973年   9篇
  1972年   16篇
  1971年   10篇
  1964年   9篇
  1940年   9篇
排序方式: 共有4969条查询结果,搜索用时 15 毫秒
61.
ABSTRACT: INTRODUCTION: Limited evidence suggests that serum alkaline phosphatase activity may decrease after cardiac surgery in adults and children. The importance of this finding is not known. Recent studies, however, have identified a potential role for alkaline phosphatase as modulator of inflammation in multiple settings, including during adult cardiopulmonary bypass. We sought to describe the change in alkaline phosphatase activity after cardiothoracic surgery in infants and to assess for a correlation with intensity and duration of post-operative support, markers of inflammation, and short-term clinical outcomes. METHODS: Sub-analysis of a prospective observational study on the kinetics of procalcitonin in 70 infants ([less than or equal to]90 days old) undergoing cardiothoracic surgery. Subjects were grouped based on the use of cardiopulmonary bypass and delayed sternal closure. Alkaline phosphatase, procalcitonin, and C-reactive protein (CRP) levels were obtained pre-operation and on post-operative day 1. Mean change in alkaline phosphatase activity was determined in each surgical group. Generalized linear modeling and logistic regression were employed to assess for associations between post-operative alkaline phosphatase activity and post-operative support, inflammation, and short term outcomes. Primary endpoints were vasoactive-inotropic score at 24 hours and length of intubation. Secondary endpoints included procalcitonin/CRP levels on post-operative day 1, length of hospital stay, and cardiac arrest or death. RESULTS: Mean decrease in alkaline phosphatase was 30 U/L (p=0.01) in the non-bypass group, 114 U/L (p<0.0001) in the bypass group, and 94 U/L (p<0.0001) in the delayed sternal closure group. On multivariate analysis, each 10 U/L decrease in alkaline phosphatase activity on post-operative day 1 was independently associated with an increase in vasoactive-inotropic score by 0.7 (p<0.0001), intubation time by 6% (p<0.05), hospital stay by 5% (p<0.05), and procalcitonin by 14% (P<0.01), with a trend towards increased odds of cardiac arrest or death (OR 1.3; p=0.06). Post-operative alkaline phosphatase activity was not associated with CRP (p=0.7). CONCLUSIONS: Alkaline phosphatase activity decreases after cardiothoracic surgery in infants. Low post-operative alkaline phosphatase activity is independently associated with increased procalcitonin, increased vasoactive/inotropic support, prolonged intubation time, and prolonged hospital stay. Alkaline phosphatase may serve as a biomarker and potential modulator of post-operative support and inflammation following cardiothoracic surgery in infants.  相似文献   
62.
63.
64.
65.
BackgroundResilience and depression may impact clinical outcomes following primary total joint arthroplasty (TJA). This study aimed to quantify baseline resilience and depression prevalence in patients undergoing primary TJA and evaluate their influence on patient-reported clinical outcomes.MethodsWe prospectively enrolled 98 patients undergoing primary TJA. Exclusion criteria included patients under 18 years of age, undergoing surgery for fracture, or who underwent additional surgery during the study period. Patients completed the Brief Resilience Scale to measure resilience, Patient Health Questionnaire-9 to measure depression, and Patient-Reported Outcomes Measurement Information System-10 to measure global physical and mental health preoperatively and 1 year postoperatively.ResultsPreoperatively, 22% and 15% of patients demonstrated major and mild depression, respectively. High resilience was identified in 34% of patients, normal resilience in 55%, and low resilience in 11%. Preoperative depression correlated with lower resilience, global physical health, and global mental health scores preoperatively as well as at 1 year after surgery (P < .001). Higher levels of preoperative resilience correlated with higher global physical and mental health scores preoperatively and at 1 year postoperatively (P < .001).ConclusionDepression symptoms are common among patients undergoing primary TJA and are associated with worse patient-reported outcomes. Patients with higher levels of resilience have higher global physical and mental health scores before and after TJA. Psychological traits and depression impact clinical outcomes following TJA.  相似文献   
66.
67.
68.
69.
70.
Outcomes management technology holds great promise for improving the quality of services provided to youth in the child welfare system. Advantages include better detection of behavioral health and trauma-related issues, early indicators of case progress or risk of failure, and program- and system-level learning. Yet organizational barriers to implementation persist. Attention is spent in this paper on addressing these barriers so the use of outcomes management technology becomes a common practice. A model for predicting resiliency is presented, along with case examples demonstrating its potential use for treatment planning and monitoring progress.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号